Trial Details
TERMINATEDBasic Information
| Clinical ID | c4569 |
|---|---|
| Identifier | NCT00307931 |
| Trial Title | Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Certolizumab pegol |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | Crete |
| Country/Region | Greece |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2007-04 |
|---|---|
| Primary Completion Date | 2008-08 |
| Completion Date | 2008-08 |